Immunotherapy for kidney cancer Doctors Abroad — Page 2

Professor Ercan Ozden serves as a medical oncology specialist at VM Medical Park Pendik Hospital, specialising in internal medicine and complex cancer therapies.

• Completed an English Medical Programme at Istanbul University Cerrahpasa Faculty of Medicine
• Broad residency training in internal medicine at a leading Turkish university hospital
• Highly specialised subspecialty training in medical oncology from Kocaeli University
• Works within the JCI-accredited Medical Park network providing evidence-based protocols

Associate Professor Hasan Mutlu leads the medical oncology department at Medical Park Antalya, specialising in next-generation genetic research and immunotherapy for organ tumours.

• Trained at Hacettepe University – one of Turkey's highest-ranking medical schools
• Awarded Associate Professorship for his work at Akdeniz University Department of Oncology
• Expert in targeted cancer therapies and complementary medicine protocols
• Specialises in using genetic research to guide personalised immunotherapy plans
• Extensive background in both internal medicine and medical oncology

Professor Alemdar is a dual-certified specialist in internal medicine and medical oncology at the Medical Park Antalya Hospital Complex.

• Trained at Akdeniz University – one of Turkey's premier medical research institutions
• Focuses on systemic therapies including targeted immunotherapy for renal cancers
• Member of the Turkish Medical Association and Turkish Society of Medical Oncology
• Experienced in treating complex oncology cases at major university and research hospitals
• Previously served at Antalya Training and Research Hospital as a senior oncology specialist

Dr. Tuncay Tas is a urological surgeon at Safe Urology Clinic in Istanbul. He is one of the first five doctors globally to publish results on P-Shot applications. Dr. Tas specializes in urological oncology and male sexual health. He completed his fellowship at Heidelberg University in Germany. His practice focuses on regenerative medicine and robotic surgery for cancer.

• Developed a surgical technique for penile enhancement with a UK-based certification.
• Introduced combined PRP and stem cell penile injections to Turkey.
• Performs robotic prostatectomies and kidney-sparing surgeries.
• Member of the International Society for Stem Cells Applications.

Associate Professor Ayse Irem Yasin holds an ESMO Board Certificate from Paris, a prestigious recognition of expertise in modern cancer protocols. She currently treats oncology patients at Medipol Acıbadem District Hospital.

• Specialises in urological cancers, including complex kidney cancer cases
• Completed clinical observerships at the Cleveland Clinic and Harvard Medical School
• Expert in managing adenocarcinomas using precision systemic therapies
• Focuses on the latest immunotherapy applications for various solid tumours

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acıbadem Regional Hospital with a specialist focus on immunotherapy and targeted therapies for solid tumours.

• Serves on the Editorial Board for BMC Cancer, a respected international medical journal
• Published over 50 scientific articles on advanced cancer treatments and patient outcomes
• Full member of the European Society for Medical Oncology (ESMO)
• Completed a clinical observership at the University of Leicester in the United Kingdom
• Specialises in managing cancer-related malnutrition and cachexia alongside oncology treatments

Associate Professor Nail Paksoy is an ESMO-certified medical oncologist specialising in complex cancer care and advanced immunotherapy protocols.

• Completed a dedicated fellowship in Allergy and Immunology, providing deep expertise in how the immune system interacts with cancer treatments
• Published specific research on outcomes for metastatic renal cell carcinoma and urothelial tumours
• Served as a sub-investigator for major international clinical trials with Roche, Pfizer, and AstraZeneca
• Holds ESMO Board Certification in Medical Oncology, an internationally recognised standard of excellence

Dr Shruti Kate leads the medical oncology department at HCG Manavata Cancer Centre and previously served at the prestigious Tata Memorial Hospital.

• Specialises in immunotherapy protocols for advanced genitourinary cancers like kidney tumours
• Member of the Immuno-Oncology Society (IOS) focusing on immune-system activation
• Awarded a solo travel grant for lung cancer research in Toronto
• Holds membership with the American Society of Clinical Oncology (ASCO)
• Uses metronomic therapy to manage aggressive solid tumours through low-dose drug delivery

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.

The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.

The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.

Dr. Shaunak Valame is a medical oncologist at HCG Manavata Cancer Centre in Nashik. He specializes in the molecular basis of cancer and targeted therapies. Dr. Valame completed his DNB training in medical oncology at Indraprastha Apollo Hospital. He previously served as a registrar at Jawaharlal Nehru Cancer Hospital.

• Presented stomach cancer research at the ASCO Gastrointestinal Cancer Symposium in San Francisco.
• Expert in chemotherapy and targeted therapy for breast, lung, and gastrointestinal cancers.
• Treats various solid tumors, pediatric cancers, and hematological malignancies.
• Works at an NABH-accredited center that treats over 75,000 patients annually.

Professor Raj Nagarkar has performed over 50,000 cancer surgeries and leads clinical research at HCG Manavata Cancer Centre.

• Trained in surgical oncology at the prestigious Tata Memorial Hospital in Mumbai
• Member of the Royal College of Surgeons, Edinburgh
• Principal investigator for over 200 clinical trials involving new cancer therapies
• Teaches the next generation of specialists as a professor for the Delhi National Board
• Publishes widely in international medical journals on oncology outcomes